Nanotechnology, the multi-disciplinary field based on the exploitation of the unique physicochemical properties of nanoparticles (NPs) and nanoscale materials, has opened a new realm of possibilities for biological research and biomedical applications. The development and deployment of mRNA-NP vaccines for COVID-19, for example, may revolutionize vaccines and therapeutics. However, regulatory and ethical frameworks that protect the health and safety of the global community and environment are lagging, particularly for nanotechnology geared towards biological applications (i.e., bio-nanotechnology). Considering this, the following review, while not comprehensive, attempts to illustrate the breadth and promise of bionanotechnology developments, and how they may present future safety and security challenges. Specifically, we address current advancements to streamline the development of engineered NPs for in vivo applications and provide discussion on nano-bio interactions, NP in vivo delivery, nano-enhancement of human performance, nanomedicine, and the impacts of NPs on human health and the environment.
Arnold, Anne M., et al. "The Promise of Emergent Nanobiotechnologies for In Vivo Applications and Implications for Safety and Security." Health Security, vol. 20, no. 5, Oct. 2022. https://doi.org/10.1089/hs.2022.0014
Arnold, Anne M., Bradley, Ashley M., Taylor, Karen L., Kennedy, Zachary C., & Omberg, Kristin M. (2022). The Promise of Emergent Nanobiotechnologies for In Vivo Applications and Implications for Safety and Security. Health Security, 20(5). https://doi.org/10.1089/hs.2022.0014
Arnold, Anne M., Bradley, Ashley M., Taylor, Karen L., et al., "The Promise of Emergent Nanobiotechnologies for In Vivo Applications and Implications for Safety and Security," Health Security 20, no. 5 (2022), https://doi.org/10.1089/hs.2022.0014
@article{osti_1900220,
author = {Arnold, Anne M. and Bradley, Ashley M. and Taylor, Karen L. and Kennedy, Zachary C. and Omberg, Kristin M.},
title = {The Promise of Emergent Nanobiotechnologies for In Vivo Applications and Implications for Safety and Security},
annote = {Nanotechnology, the multi-disciplinary field based on the exploitation of the unique physicochemical properties of nanoparticles (NPs) and nanoscale materials, has opened a new realm of possibilities for biological research and biomedical applications. The development and deployment of mRNA-NP vaccines for COVID-19, for example, may revolutionize vaccines and therapeutics. However, regulatory and ethical frameworks that protect the health and safety of the global community and environment are lagging, particularly for nanotechnology geared towards biological applications (i.e., bio-nanotechnology). Considering this, the following review, while not comprehensive, attempts to illustrate the breadth and promise of bionanotechnology developments, and how they may present future safety and security challenges. Specifically, we address current advancements to streamline the development of engineered NPs for in vivo applications and provide discussion on nano-bio interactions, NP in vivo delivery, nano-enhancement of human performance, nanomedicine, and the impacts of NPs on human health and the environment.},
doi = {10.1089/hs.2022.0014},
url = {https://www.osti.gov/biblio/1900220},
journal = {Health Security},
issn = {ISSN 2326-5094},
number = {5},
volume = {20},
place = {United States},
publisher = {Mary Ann Liebert, Inc.},
year = {2022},
month = {10}}